Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 23278125)

Published in Aliment Pharmacol Ther on December 20, 2012

Authors

K V Menon1, A R Hakeem, N D Heaton

Author Affiliations

1: Institute of Liver Studies, King's College Hospital, London, UK.

Articles citing this

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation. Biomed Res Int (2017) 1.40

Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol (2014) 1.06

Hepatocellular carcinoma: A comprehensive review. World J Hepatol (2015) 0.98

Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol (2014) 0.96

Mammalian target of rapamycin inhibition in hepatocellular carcinoma. World J Hepatol (2014) 0.94

Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. PLoS One (2013) 0.88

Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol (2013) 0.83

Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82

Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol (2015) 0.81

Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World J Gastroenterol (2015) 0.81

Management of hepatocellular carcinoma: an overview of major findings from meta-analyses. Oncotarget (2016) 0.81

Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun. Surg Today (2016) 0.81

Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma. World J Hepatol (2015) 0.80

Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence. Ann Gastroenterol (2015) 0.79

Review on immunosuppression in liver transplantation. World J Hepatol (2015) 0.79

Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation. Langenbecks Arch Surg (2013) 0.79

Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78

Liver transplantation for malignancy: current treatment strategies and future perspectives. World J Gastroenterol (2014) 0.78

Reduced red blood cell count predicts poor survival after surgery in patients with primary liver cancer. Medicine (Baltimore) (2015) 0.78

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78

Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol (2016) 0.77

Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77

Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response. BMC Cancer (2015) 0.77

Care of the liver transplant patient. Can J Gastroenterol Hepatol (2014) 0.77

Surgical treatment for hepatocellular carcinoma. Saudi J Gastroenterol (2015) 0.77

Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol (2014) 0.76

Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma. Liver Transpl (2016) 0.76

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review. World J Gastroenterol (2016) 0.75

Systemic treatment for hepatocellular carcinoma: Still unmet expectations. World J Hepatol (2017) 0.75

Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma. Curr Opin Virol (2016) 0.75

Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma (2017) 0.75

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatol (2014) 0.75

Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence. Transl Gastroenterol Hepatol (2016) 0.75

Articles by these authors

Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg (2001) 1.74

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther (2010) 1.60

Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med (2001) 1.45

Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. QJM (2000) 1.45

Hemangioendothelioma of the liver in infants. J Pediatr Surg (1995) 1.42

Intraoperative cardiac tamponade after central venous cannulation in an infant during orthotopic liver transplantation. Anesth Analg (1999) 1.42

Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation (1998) 1.35

Hepatic artery pseudoaneurysms following liver transplantation: incidence, presenting features and management. Clin Radiol (2001) 1.32

De-novo autoimmune hepatitis after liver transplantation. Lancet (1998) 1.30

Accessory right hepatic artery arising from the left: implications for split liver transplantation. Transplantation (1998) 1.26

Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg (1995) 1.20

Body packing--a case report and review of the literature. Postgrad Med J (1990) 1.20

Spontaneous perforation of the bile duct in infants. Br J Surg (1991) 1.04

Laparoscopic cholecystectomy injury: an unusual indication for liver transplantation. Transpl Int (1998) 1.00

A prospective randomised trial of bile duct reconstruction at liver transplantation: T tube or no T tube? Transpl Int (1996) 0.98

Developmental intrahepatic shunts of childhood: radiological features and management. Eur Radiol (1997) 0.97

Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol (2000) 0.96

Liver transplantation with monosegments. Surgery (1999) 0.95

Surgical anatomy of segmental liver transplantation. Br J Surg (2002) 0.95

The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant (2006) 0.95

Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med (2000) 0.93

Splenic artery aneurysm and orthotopic liver transplantation. Transpl Int (1999) 0.93

Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg (1999) 0.91

Liver transplantation in adults coinfected with HIV. Transplantation (2001) 0.91

Bowel perforation after paediatric orthotopic liver transplantation. Transpl Int (1998) 0.90

Review article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria. Aliment Pharmacol Ther (2014) 0.90

Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut (2006) 0.89

Islet cell transplantation. Postgrad Med J (2007) 0.88

Liver transplantation for alpha-1-antitrypsin deficiency in children. Transpl Int (2000) 0.88

Isolated liver transplant and sequential small bowel transplantation for intestinal failure and related liver disease in children. Transplantation (2000) 0.87

Hepatic artery thrombosis after liver transplantation in children under 5 years of age. Transplantation (1996) 0.87

Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology (2001) 0.87

Paediatric liver transplantation: the surgical view. Postgrad Med J (2004) 0.86

Diaphragmatic nerve palsy in young children following liver transplantation. Successful treatment by plication of the diaphragm. Transpl Int (1998) 0.86

Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterol Nutr (2000) 0.85

Orthotopic liver transplantation for acute hepatic failure in children. Transpl Int (1994) 0.85

Organ transplantation in hereditary apolipoprotein AI amyloidosis. Am J Transplant (2006) 0.85

Use of bacteriology in anorectal sepsis as an indicator of anal fistula: experience in a distinct general hospital. J R Soc Med (1990) 0.85

MnDPDP-enhanced MR imaging of the liver. Correlation with surgical findings. Acta Radiol (1997) 0.84

Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant (2010) 0.83

Liver transplantation for neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed (1995) 0.82

Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant Proc (2005) 0.82

Patterns of portal vein occlusion and their aetiological significance. Br J Surg (1994) 0.82

Split-liver transplantation. Br J Surg (1998) 0.82

The incidence and management of biliary complications following liver transplantation in children. Transpl Int (1995) 0.82

Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel. Transpl Int (1999) 0.82

Induction and role of NO synthase in hypotensive hepatic failure. Arterioscler Thromb Vasc Biol (1997) 0.81

Auxiliary liver transplantation for metabolic diseases. Transplant Proc (1997) 0.81

Recurrence of Langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation (2000) 0.81

Orthotopic liver transplantation for hepatic-based metabolic disorders. Transpl Int (1995) 0.81

Manganese-enhanced MRI predicts the histological grade of hepatocellular carcinoma in potential surgical candidates. Clin Radiol (2010) 0.79

Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience. Transplantation (2003) 0.79

Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation (2001) 0.79

Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation. J Pediatr Surg (2001) 0.78

Orthotopic liver transplantation for hepatic complications of Wilson's disease. Br J Surg (1993) 0.78

Chronic rejection in pediatric liver transplantation. Transplant Proc (1997) 0.78

Replacement of the retrohepatic vena cava in segmental liver transplantation. Transpl Int (1997) 0.78

Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy. Transplantation (1998) 0.77

Liver transplant for giant cell hepatitis with autoimmune haemolytic anaemia. Arch Dis Child (1997) 0.77

An investigation into the risk of air embolus during veno-venous bypass in orthotopic liver transplantation. Transplantation (1999) 0.77

Understanding "marginal" liver grafts. Transplantation (1999) 0.77

Liver transplantation for acute liver failure in children under 1 year of age. Transplant Proc (1997) 0.77

Reducing bile leak following segmental liver transplantation: understanding biliary anatomy of the caudate lobe. Am J Transplant (2007) 0.77

Congenital absence of the portal vein in liver transplantation for biliary atresia. Int J Surg Investig (2000) 0.77

Development of techniques for obtaining monodispersed human islet cells. Transplantation (1994) 0.77

Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure. Transplant Proc (2005) 0.77

Variation of a variation: case report of attenuated familial adenomatous polyposis. HPB (Oxford) (2006) 0.77

A validated technique for the analysis of biliary bile acid secretion in donor livers prior to transplantation. Transpl Int (1998) 0.77

Graft-versus-host disease following liver transplantation. J R Soc Med (1992) 0.77

Liver transplantation for fulminant liver failure in children. Transpl Int (1992) 0.76

Orthotopic liver transplantation for primary sclerosing cholangitis. Transplant Proc (1994) 0.76

Nitric oxide synthase induction and chronic cardiac allograft rejection. Transplant Proc (1995) 0.76

Ex vivo liver surgery for extraadrenal pheochromocytoma. Pediatr Surg Int (2005) 0.76

Liver transplantation for fulminant hepatic failure and late-onset hepatic failure in children. Br J Surg (1992) 0.76

Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation. Transplant Proc (2005) 0.76

Selective arterial embolisation for hepatic trauma. Ann R Coll Surg Engl (1991) 0.75

Strangulated femoral hernia: the clinical trap. Postgrad Med J (1991) 0.75

Gender matching and outcome after pediatric liver transplantation. Transplantation (1998) 0.75

Congenital hepatic arterioportal fistula. J Pediatr Gastroenterol Nutr (1999) 0.75

Importance of the unilateral absence of the vas. Br J Surg (1991) 0.75

Gangrene of the anterior abdominal wall after orthotopic liver transplantation: invasive cutaneous candidiasis. Postgrad Med J (1993) 0.75

The use of percutaneous transluminal angioplasty in hepatic artery stenosis after transplantation. Transplantation (1994) 0.75

Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients. Transplantation (2001) 0.75

Liver transplantation in Polysplenia syndrome. Transplantation (2001) 0.75

Split liver transplantation: a way forward? Transplant Proc (1997) 0.75

Use of cadaveric superior mesenteric artery as interpositional vascular graft in orthotopic liver transplantation. Br J Surg (2001) 0.75

Extended abdominal rectopexy. Br J Surg (1988) 0.75

A technique for hepatic artery anastomosis during orthotopic liver transplantation. Transpl Int (1995) 0.75

Liver transplantation from living related donors: review of world experience and its implications for India. Indian J Pediatr (1995) 0.75

Small bowel flora and bacterial translocation in potential small bowel transplant donors. Transplant Proc (1996) 0.75

Mycobacterium tuberculosis infection in pediatric liver transplant recipients. Pediatr Infect Dis J (2000) 0.75

Non-anatomical reduction of liver allografts: a promising option for neonates with fulminant hepatic failure. Transplant Proc (1997) 0.75

Liver transplantation for Langerhans' cell histiocytosis--a case report and literature review. Transplantation (1996) 0.75

Easy, cheap, and reliable identification of ganglion cells. Am J Clin Pathol (1986) 0.75

Successful orthotopic liver transplantation for fulminant liver failure in a child with autosomal recessive chronic granulomatous disease. Transplantation (1995) 0.75

Rectus abdominis muscle flap. Br J Surg (1989) 0.75

Living related liver transplantation in biliary atresia with absent inferior vena cava. Liver Transpl (2001) 0.75

Patient perception of skin-cancer prevention and risk after liver transplantation. Clin Exp Dermatol (2013) 0.75

Anti-thymocyte globulin, cyclosporin A and granulocyte colony-stimulating factor for severe aplastic anaemia complicating paediatric liver transplantation. Eur J Pediatr (1998) 0.75